{
    "2018-12-17": [
        [
            {
                "time": "2018-12-10~2018-12-16",
                "original_text": "每周医药生物行业机构观点选编（2018年12月10日~12月16日）",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "机构观点",
                        "政策"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-12-17",
                "original_text": "12月17日 主力资金抢筹最积极的前10股（附名单）",
                "features": {
                    "keywords": [
                        "主力资金",
                        "抢筹",
                        "股票名单"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-17",
                "original_text": "市场 | 创新药、仿制药，冰火两重天",
                "features": {
                    "keywords": [
                        "创新药",
                        "仿制药",
                        "市场对比"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-17",
                "original_text": "医药生物行业：国家级辅助用药目录将出台,医保转移利好刚性用药企业",
                "features": {
                    "keywords": [
                        "医药生物",
                        "政策",
                        "辅助用药",
                        "医保",
                        "刚性用药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-12-17",
                "original_text": "北上资金周流入放缓 消费和基建龙头受青睐",
                "features": {
                    "keywords": [
                        "北上资金",
                        "消费",
                        "基建",
                        "龙头"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费",
                        "基建"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-17",
                "original_text": "A股低位震荡不改“聪明资金”流向 24股上演建仓大戏",
                "features": {
                    "keywords": [
                        "A股",
                        "低位震荡",
                        "聪明资金",
                        "建仓"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-17",
                "original_text": "医药生物行业周报:政策多发扰动期,建议关注品牌中药的配置价值",
                "features": {
                    "keywords": [
                        "医药生物",
                        "政策",
                        "品牌中药",
                        "配置价值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            }
        ]
    ]
}